retatrutide phase 2 trial results weight loss for loss: Study shows 30% body weight Retatrutide Helped Adults With Obesity

What this means for overall gut health overall gut health Potential positives: Less glycemic volatility (fewer glucose-driven GI symptoms in some with diabetes) Reduced reflux triggers for some if weight loss decreases intra-abdominal pressure Improved MASLD/MASH biomarkers via weight loss and metabolic effects Lower overall intake may calm visceral hypersensitivity in some IBS-D cases Potential challenges: Delayed emptying early fullness, nausea, reflux, or vomiting if portions/fats are too high Constipation in those with slow motility or low fiber/fluid intake Gallstones with rapid loss Undernutrition may contribute to overall symptoms and inflammation impacting the gut Poor balance of meals due to low intake may negatively impact the gut microbiome Rare but serious pancreatitis or ileus requiring immediate care The bottom line is that these medications arent 100% good or 100% bad

A recent study found that patients with type 2 diabetes taking a GLP-1 receptor agonist (such as Mounjaro) may be at an increased risk for developing the debilitating condition

Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus

Promotes Healthy Aging Support Helps maintain cellular vitality and supports overall wellness